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Abstract
The pathway by which rotavirus is released from the cell is poorly understood but recent work has shown that, prior to cell lysis, rotavirus
is released almost exclusively from the apical surface of the infected cell. By virtue of their unique biochemical and physical properties,
viruses have exploited lipid rafts for host cell entry and/or assembly. Here we characterized the association of rhesus rotavirus (RRV) with
lipid rafts during the rotavirus replication cycle. We found that newly synthesized infectious virus associates with rafts in vitro and in vivo.
RRV proteins cosegregated with rafts on density gradients. Viral infectivity and genomic dsRNA also cosegregated with the raft fractions.
Confocal microscopic analysis of raft and RRV virion proteins demonstrated colocalization within the cell. In addition, cholesterol depletion
interfered with the association of RRV particles with rafts and reduced the release of infectious particles from the cell. Furthermore, murine
rotavirus associates with lipid rafts in intestinal epithelial cells during a natural infection in vivo. Our results confirm the association of
rotavirus infectious particles with rafts during replication in vitro and in vivo and strongly support the conclusion that this virus uses these
microdomains for transport to the cell surface during replication.
© 2003 Elsevier Science (USA). All rights reserved.
Introduction
Rotaviruses are well established as the single most im-
portant cause of severe diarrhea requiring hospitalization in
infants and young children around the world. Diarrheal
disease caused by rotaviruses is associated with more than
600,000 deaths per year, predominantly in developing coun-
tries (Bresee et al., 1999). Currently, a vaccine to prevent
rotavirus disease is not available and studies to identify a
safe and effective vaccine are urgently needed. These non-
enveloped viruses are composed of three layers of protein
and 11 segments of double-stranded RNA (dsRNA) that
encode six structural and six nonstructural proteins (Estes,
2001). Infection with these viruses is highly restricted in
vivo to the mid and upper villous epithelium of the small
intestine, leading to cell death and villus atrophy (Estes,
2001).
The mechanism by which nonenveloped viruses are re-
leased from the infected cell is still poorly understood.
Historically it has been assumed that these viruses are pri-
marily released to the external media after cellular lysis.
However, studies with simian virus 40 (SV40) and poliovi-
rus have indicated that nonenveloped viruses may also be
transported to specific plasma membrane domains using a
vesicular transport mechanism (Clayson et al., 1989; Tucker
et al., 1993).
Rotavirus replication occurs in large inclusions in the
cell cytoplasm designated as viroplasm (Estes, 2001). The
maturation of these viruses undergoes a unique process in
which double layered particles assembled in the viroplasm
translocate across the endoplasmic reticulum (ER) mem-
brane. This process is mediated by interactions between
VP6 and the nonstructural transmembrane glycoprotein
NSP4 (Estes, 2001). During transit through the ER, the virus
acquires a transient lipid envelope that is eventually lost and
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replaced by the outer capsid proteins, VP7 and VP4 (Estes,
2001). Analysis of the transport and release of rhesus rota-
virus (RRV) from polarized human intestinal Caco-2 cells
showed that RRV is released almost exclusively from the
apical surface of polarized Caco-2 cells before evidence of
cellular lysis by a nonconventional vesicular mechanism
that does not involve transit through the Golgi complex
(Jourdan et al., 1997).
To perform its function as a barrier to the external envi-
ronment, epithelial cells have developed a highly polarized
structure and possess distinct compositions of lipids and
proteins on their apical and basolateral membranes; for
example, glycosphingolipids and sphingomyelin are en-
riched in the apical surface, while phosphatidylcholine is the
dominant lipid in the basolateral membrane (Simons and
van Meer, 1988).
Glycosphingolipids, cholesterol, and proteins can inter-
act specifically in cell membranes to form microdomains
termed rafts (Simons and Ikonen, 1997). These microdo-
mains are considered a liquid-ordered phase of the mem-
brane that floats freely in the liquid-disordered phase of the
lipid bilayer (Brown and London, 1998) and have been
considered sorting centers for delivery of lipids and proteins
destined to the apical surface (Brown and Rose, 1992;
Simons and Ikonen, 1997; Simons and van Meer, 1988;
Simons and Wandinger-Ness, 1990).
Over the past years increasing evidence has been accu-
mulated to support the idea that many pathogens such as
bacteria, parasites, and viruses use lipid rafts or the related
cell-surface structure termed caveolae for their own benefit.
Due to their propensity to concentrate receptors and signal
transduction molecules, lipid rafts constitute centers from
which multiple signaling pathways originate (Anderson,
1993; Sargiacomo et al., 1993; Simons and Ikonen, 1997).
This attribute has been exploited for certain viruses such as
HIV, SV40, and vesicular stomatitis virus that use rafts or
caveolae as host cell entry sites (Manes et al., 2000; Parton
and Lindsay, 1999; Werling et al., 1999). In addition, due to
their role in membrane sorting and intracellular trafficking,
raft domains also provide sites for assembly or budding of
enveloped viruses such as influenza virus, HIV measles
Ebola, and Marburg (Campbell et al., 2001; Scheiffele et al.,
1999; Vincent et al., 2000). Recently studies directed to
understand rotavirus assembly and release showed that VP4
is associated with rafts and targeted to the plasma mem-
brane as early as 3 h after infection. The interaction of VP4
and purified virions with model membranes that resemble
lipid rafts, and the presence of infectious rotavirus particles
in these detergent resistant membranes, indicated that VP4
is responsible for the association of rotavirus particles with
membranes and suggested that rotavirus uses rafts as as-
sembly platforms (Sapin et al., 2002).
To better understand the release of rotavirus during in-
fection, we have characterized the association of RRV with
lipid rafts during the replication process.
Results
The mechanism by which rotavirus and other nonenvel-
oped viruses are released from the cell surface is poorly
understood. Since recent work on the transport and release
of rotavirus from polarized intestinal Caco-2 cells has
shown that RRV is released almost exclusively from the
apical surface of the infected cell (Jourdan et al., 1997), and
raft microdomains have also been implicated in apical tar-
geting of VP4 (Sapin et al., 2002), we characterized the
association of RRV with lipid rafts during replication.
Rotavirus proteins migrate with the raft-containing
fraction
Rafts microdomains are resistant to nonionic detergent
extraction at low temperatures, and these detergent-insolu-
ble complexes float to a low density during isopycnic gra-
dient centrifugation making possible a physical separation
from the bulk of soluble cellular membranes (Brown and
London, 1998; Brown and Rose, 1992). To gain more in-
sight in the association of de novo synthesized RRV pro-
teins with lipid rafts, we analyzed the detergent insolubility
of the membrane component of rotavirus-infected Caco-2
cells during a pulse-chase experiment. After a 15 min 35S
pulse; and different chase times, RRV-infected cells were
extracted in TX-100, and the lysate was layered on an
Optiprep equilibrium density gradient, fractionated, and an-
alyzed by electrophoresis on SDS polyacrylamide gels
(Figs. 1A–C). Although a substantial amount of the newly
synthesized rotavirus proteins accumulated in the nonlipid
raft fractions (f9–f13), TX- 100 failed to solubilize a frac-
tion of newly produced RRV proteins. At the end of the
pulse, viral structural proteins VP2, VP4, VP6, and VP7 and
nonstructural protein NSP4 were clearly detected in the
detergent-insoluble fractions even after a short chase period
(Fig. 1A, f4–f5) and an increase in the RRV protein content
in these insoluble fractions became evident with 60 min of
chase (Fig. 1C). The identity of VP2, VP4, VP6, and VP7 in
the gradient fractions was confirmed by Western blot; the
identification of NSP4 was done by immunoprecipitation
using a monoclonal antibody (mAb) that specifically recog-
nizes NSP4 (data not shown). The presence of another
nonstructural protein in the raft-containing fraction was
examined by Western blot analysis using a mAb that spe-
cifically reacts with NSP2. We found that the proportion of
NSP2 in f4 was barely detectable and, unlike NSP4, not
enriched with respect to the neighboring fractions (data not
shown). To rule out the possibility that the detergent ex-
traction might have been incomplete and have inadvertently
trapped some rotavirus proteins in the insoluble fraction
(f4), we reextracted the material contained in fraction 4 with
fresh cold TX-100 lysis buffer and repeated the buoyant
density gradient (Fig. 1D). The rotavirus proteins were
highly enriched in the detergent-resistant fraction in this
gradient (f4), showing that the interaction of RRV proteins
309M.A. Cuadras, H.B. Greenberg / Virology 313 (2003) 308–321
with TX-100-insoluble membranes was stable and not due
to incomplete extraction.
We looked for the presence of a raft protein marker to
confirm that the rotavirus-containing fractions (Fig. 1, f4
and f5) corresponded to rafts containing fractions. PLAP is
a glycosylphosphatidyl inositol (GPI) anchored membrane
protein that associates with rafts (Brown and Rose, 1992).
Western blots of the density gradient fractions using a
monoclonal antibody against placental alkaline phosphatase
(PLAP) showed that this protein was insoluble in TX-100
and accumulated mainly in fraction 4 (Figs. 1E and F). On
the other hand, Western blot analysis of calnexin (an ER
resident chaperone) showed that this protein was enriched in
f7–f13, indicating that ER membranes were not contami-
nating the raft fraction. To rule out the possibility that
rotavirus infection itself alters the detergent partitioning of
rafts, we analyzed noninfected cells and again detected
PLAP migration in fractions 4–5 by Western blot (data not
shown). These findings confirm that de novo synthesized
rotavirus structural proteins and NSP4 rapidly associate
with and accumulate in the raft-containing fractions in in-
fected Caco-2 cells as early as 6 hours postinfection (hpi).
Viral infectious particles segregate intracellularly with
rafts
The flotation of RRV proteins in the raft-containing
fraction reflected events that took place intracellularly and
was not an intrinsic feature of preformed rotaviral particles,
since viral particles were not recovered in the detergent-
insoluble fraction when a preparation of CsCl-purified in-
fectious triple-layer particles was mixed with a cellular
lysate of Caco-2 cells (extracted with cold TX-100 lysis
buffer) in vitro and then subjected to equilibrium centrifu-
gation in a reconstitution experiment (Fig. 2A). To provide
direct evidence that the radiolabeled proteins migrating in
the low-density fraction (f4) were contained in viral parti-
cles and not merely soluble, non-virus-associated proteins,
we pelleted the virus from each gradient fraction by ultra-
centrifugation and performed gel electrophoresis of the pel-
leted material (Fig. 2B). As expected, rotavirus structural
proteins including VP7 were clearly enriched in f4, suggest-
ing that triple-layered particles migrate in the raft-contain-
ing fraction. Interestingly, because detergent-resistant mem-
branes represent only a small fraction of the whole cellular
Fig. 1. Rotavirus proteins migrate with the raft containing fractions. (A–C) Rotavirus-infected Caco-2 cells were pulse labeled with [35S]methionine-cysteine
and chased for 0 (A), 20 (B), or 60 (C) min. The cells were lysed with cold 1% TX-100 and rafts were purified as described under Materials and methods.
(A–C) SDS–PAGE and fluorography. (E–F) Western blot analysis of each fraction for PLAP detection. (D) Second TX-100 extraction of 60 min fraction
4.
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extract, the relative concentration of rotavirus structural
proteins within the raft fraction may be relatively higher
than the concentration of viral proteins within the soluble
pool. Of note, NSP4 was no longer detected in the raft-
containing fraction after pelleting, suggesting that this pro-
tein is not directly associated with viral particles and might
function as a transmembrane raft receptor for double-lay-
ered particles (DLPs). Two additional observations can be
made regarding the pelleted material from f9–f13: First, the
reduction of 35S-labeled proteins in these fractions (com-
pare with bottom fractions of Fig. 1) shows that the majority
of the synthesized viral proteins remain cytoplasmic or
associated with soluble membranes (perhaps the ER), since
they are extracted with cold nonionic detergent and migrate
with the soluble cytoskeleton components after buoyant
density centrifugation. Second, the different proportions of
structural proteins partially pelleted from nonlipid raft-con-
taining fractions suggests that these proteins are probably
derived from a mixed population of triple-layed particles
(TLPs) DLPs, and replication intermediates particles.
We next investigated whether the increase of viral pro-
teins in the raft fractions reflected an association of infec-
tious rotavirus with rafts. We measured infectivity and
genomic dsRNA in each fraction of the OptiPrep gradients.
Genomic dsRNA was subjected to polyacrylamide gel elec-
trophoresis and stained with silver nitrate (Fig. 2C). The 11
Fig. 2. Viral infectious particles segregate with rafts intracellularly. (A) 35S-labeled TLPs were mixed with a cold cellular TX-100 lysate of Caco-2 cells in
a reconstitution experiment and subjected to ultracentrifugation in an OptiPrep density gradient as described under Materials and methods. After fractionation,
an aliquot of each fraction was analyzed by SDS–PAGE and fluorography. (B) Cellular extracts from rotavirus-infected Caco-2 cells were prepared by
treatment with cold TX-100 lysis buffer and fractionated as described in Fig. 1C. Each fraction was diluted in TNC and concentrated by ultracentrifugation.
The pelleted material was resuspended in TNC and subjected to SDS–PAGE electrophoresis. The migration of the viral structural proteins is indicated; both
gels were 12% polyacrylamide and did not resolve the separation between VP2 and VP4, but the identity of these two proteins was confirmed by Western
blot (not shown). (C) 100 l from each fraction of the 60-min chase (Fig. 1A) were used to purify rotavirus genomic dsRNA; the RNA was subjected to
polyacrylamide gel electrophoresis and detected by staining with silver nitrate. *dsRNA purified from a lysate of RRV infected MA104 cells. (D) Infectivity
assay. Fractions from 60-min chase experiment titered on MA104 cells by FFU. Results are expressed as percentage of infectivity where 100% (6.5  107
FFU/ml) represents the fraction with highest infectivity for each titration. Values are means from at least three experiments. The standard error is indicated.
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segments of rotavirus dsRNA were detected and an increase
of viral dsRNA was found in the raft-containing fraction in
comparison with fractions 1, 2, 3, 5, 6, and 7. Repetition of
this experiment several times indicated that very low levels
of dsRNA were also present in fractions 5–11 but the
amount of dsRNA in these fractions was barely detectable
under our staining conditions. Nuclear remnant and cy-
toskeleton-associated dsRNA migrated in the soluble frac-
tions and pellet of the gradient (Fig. 2, fractions 8–13). To
confirm that the dsRNA detected in f4 corresponded to
RNA associated with infectious TLPs, we measured viral
infectivity in each fraction. An increase of viral infectivity
was found in fraction 4 in comparison with the neighboring
fractions (Fig. 2D). Surprisingly, although the absolute
quantity of rotavirus dsRNA in fractions 12 and 13 was
substantially greater than observed in fraction 4, the infec-
tivity of fraction 4 was increased between 70–80% in com-
parison with the infectivity of these two fractions. To rule
out the possibility that the lipid constituents of the raft
fraction were facilitating the entrance and replication of
immature double-layer particles during the infectivity assay,
we incubated an aliquot of each fraction with neutralizing
mAb 159, directed at VP7, and confirmed that all the infec-
tivity showed in Fig. 2D, fraction 4 was neutralized and
hence attributable to mature triple layer particles (not
shown). Taken together, these results demonstrate that in-
fectious triple-layered particles accumulate in rafts in rota-
virus-infected Caco-2 cells.
In vivo colocalization of rotavirus particles and GM1
The association of rotavirus particles with lipid rafts in
situ prior to detergent extraction was investigated by dou-
ble-indirect immunofluorescence staining and confocal mi-
croscopy. GM1 is a ganglioside commonly used as lipid raft
marker because this glycosphingolipid is highly enriched in
detergent-insoluble domains of the plasma membrane (Or-
landi and Fishman, 1998). The B subunit of cholera toxin
(ChTx) binds with high affinity to GM1 and has been used to
visualize this glycosphingolipid (Harder et al., 1998; Pickl
et al., 2001). Colocalization experiments of GM1 and rota-
virus particles were performed on infected Caco-2 cells
using biotin-labeled ChTx and mAbs against rotavirus pro-
teins VP6 and VP7. In noninfected Caco-2 cells ChTx
binding exhibited an even distribution over the cell (Fig.
3A). In RRV-infected cells the signal for ChTx was also
generally found over the cell but in addition, occasional
patches of staining of aggregates in perinuclear regions and
contact zones between cells were evident (Fig. 3B–D). By
use of double staining, it was possible to show that the
formation of these aggregates exclusively occurs in infected
cells (e.g., compare left and middle of Fig. 3B). These
findings suggest that rotavirus infection induces a rearrange-
ment and aggregation in the distribution of GM1.
VP6, the major constituent of the double-layered parti-
cle, was detected with mAb 255/60. VP6 was found distrib-
uted in patches throughout the cytoplasm (Fig. 3B, middle);
this type of distribution had previously been reported to
correspond to viroplasmic inclusions (Gonzalez et al.,
2000). When analyzed in conjunction with ChTx staining,
VP6 was predominantly excluded from patches of GM1 (Fig.
3B, right panel).
The outer capsid glycoprotein VP7 is a luminal ER
resident protein, which is thought to be assembled into the
virus particle during the transit of the double-layered parti-
cle through the ER (Estes, 2001). When we analyzed the
distribution of VP7 using mAb 60, which primarily recog-
nizes a cytoplasmic nonvirion associated form of VP7 (Dor-
mitzer et al., 1992), staining was seen surrounding and
projecting from the nuclear region (Fig. 3A, middle). This
pattern correlates with VP7’s previously described ER as-
sociation (Gonzalez et al., 2000). When we compared the
distribution of VP7 with that of GM1, we found that in the
majority of the infected cells these two markers did not
cosegregate. However, in some cells VP7 staining over-
lapped with ChTx staining (Fig. 3C, right). The coincidence
of the signal for GM1 and VP7 observed with mAb 60 in
conjunction with the results presented in Figs. 1 and 2
suggested that triple-layered particles (which contain a mi-
nor component of the total VP7 in the cell) might colocalize
with rafts in vivo. This colocalization was confirmed using
monoclonal antibody 159. This mAb is a conformationally
sensitive antibody and recognizes VP7 almost exclusively
when it is assembled in mature virus particles (Dormitzer et
al., 1992). As seen in Fig. 3D, some overlap of VP7 (mAb
159) staining and the lipid raft marker GM1 demonstrated
the colocalization of triple-layered complete viral particles
with rafts in the cell cytoplasm. Taken together, these find-
ings provide additional evidence to conclude that the asso-
ciation of the de novo synthesized rotavirus particles with
rafts takes place in vivo and is not an artifact of the deter-
gent extraction process.
Cholesterol interfering drugs alters the segregation of
RRV proteins into the raft fraction
Cholesterol has been postulated to be a crucial compo-
nent of rafts. According to the model proposed by Simons
and co-workers, rafts are semiordered domains within the
fluid lipid biliayer (Brown and London, 1998). They are
formed by glycosphingolipids closely packed laterally with
each other and with molecules of cholesterol filling the
spaces that tend to form between the carbohydrate head
groups (Simons and Ikonen, 1997).
The preceding results indicated that infectious rotavirus
particles associate with rafts. To determine the involvement
of cholesterol in this association, we analyzed the raft as-
sociation of virion proteins in cholesterol-depleted cells.
Cyclodextrins are water-soluble cyclic oligosaccharides that
have the capacity to sequester cholesterol in their hydro-
phobic cavity, removing cholesterol from cells rapidly and
efficiently (Kilsdonk et al., 1995). We treated infected
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Caco-2 cells for 60 min with 10 mM methyl--cyclodextrin
(mcdx), as this treatment has previously been shown to
decrease the cholesterol content of the plasma membrane by
60–70% (Keller and Simons, 1998), without interfering
with cellular viability (Keller and Simons, 1998 and not
shown). Subsequently, the cells were radioactively labeled
and chased, and the raft containing fractions was separated
from the bulk cell extract of the TX-100-insoluble material
and analyzed by SDS–PAGE (Fig. 4). Cholesterol depletion
with mcdx altered the migration of RRV particles in the
gradient, leading to a reduction of rotavirus proteins in the
raft fraction (f4) and a slight peak in fraction 6 (compare
figs. 4A and B). Densitometric analysis of the percentage of
viral proteins over the 13 fractions of the gradient under this
Fig. 3. Rotavirus particles colocalize with GM1. Caco-2 cells were grown on plastic coverslips and mock- (A) or rotavirus-infected (B–D) for 16 h. The cells
were fixed, permeabilized, and coincubated with biotin-labeled ChTx and the indicated antirotavirus mAb. After washing, streptavidin-FITC and mouse
Txred were added. The preparations were analyzed by confocal microscopy. The left panel shows distribution of GM1 in the different experiments; the middle
panel shows the distribution of different rotavirus proteins, and the right panel shows the merging of the two signals. The monoclonal antibodies used for
the staining of rotavirus proteins were as follows: (B) mAb 255/60 detects VP6, (C) mAb 60 detects VP7 and (A, D) mAb 159 detects VP7 on virions. All
images were obtained with 40 objective.
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treatment showed that 3.9% of VP6, 4.1% of VP7, and 4.7%
of NSP4 migrated in the insoluble component of the gradi-
ent (f4) (Fig. 4E).
We also used mevinolin, an inhibitor of hydroxymethyl-
glutaryl-CoA (HMG- CoA), the rate limiting enzyme in
cholesterol biosynthesis, to further examine the interaction
of rotavirus with rafts. Inhibition of endogenous cholesterol
synthesis by mevinolin treatment had less effect on parti-
tioning of the viral particles into the insoluble lipid fraction
(Figs. 4C and E). The percentage of VP6, VP7, and NSP4 in
fraction 4 was 11.7, 5.9, and 4.9%, respectively. However,
coincubation of the cells with mcdx plus mevinolin (Fig.
4D) enhanced the effect of either drug alone. Under this
condition, only between 2 and 2.9% of the viral proteins
remained insoluble to TX-100 (Fig. 4E). It is important to
mention that even after treatment with mcdx, mevinolin,
or both drugs some dsRNA is still detected in fraction 4 (not
shown), suggesting that these treatments only partially re-
duced the cellular cholesterol content and that the residual
cholesterol might be able to maintain a reduced number of
functional rafts microdomains.
Viral release is affected by drugs that compromise lipid
raft integrity
The biochemical characterization presented above dem-
onstrated that rotavirus infectious particles associate with
rafts during replication and that their association was de-
creased by removal of cholesterol from the cell. To deter-
mine if this association was functionally important for the
Fig. 4. Rotavirus-rafts association requires cholesterol. After 5 h of infection Caco-2 cells were untreated (A) or treated with 10 mM mcdx (B) for 60 min;
the cells were 35S-labeled and chased in the presence of the drug. For the treatment with mevinolin (C) the cells that were preincubated with a 10 M
mevinolin for 36 h prior infection and labeling. For the combined treatment of the two drugs (D), the cells were treated with mevinolin, infected with rotavirus,
and then incubated with mcdx as in B. Each drug was maintained in the starvation, labeling, and chase media. Cellular extracts were prepared by treatment
with cold TX-100 lysis buffer and fractionated as described in Fig. 1. Fractions were analyzed by SDS–PAGE and fluorography. (E) Quantitation of rotavirus
proteins in the raft fraction. The radioactive signal for rotavirus proteins VP6, VP7, and NSP4 in the gels shown in A–D was quantified by densitometry.
Results are expressed as percentage of the indicated viral protein in f4; 100% represents the sum of the signal for each protein over the 13 fractions.
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release of virus from the cell, we performed a virus release
assay in cells treated with mcdx and/or mevinolin. As seen
(Fig. 5), the release of infectious virus into the medium was
reduced by 80% in cells treated with mcdx, while the
treatment of cells with mevinolin reduced the infectivity in
the supernatant by 65%. An increase in the inhibition of
viral release was observed when the infected cells were
coincubated with both drugs; only 10% of control viral
progeny was detected in the supernatant of the infected
cells.
As previously described (Jourdan et al., 1997), a 4-h
treatment of infected cells with CCCP, an uncoupler of
oxidative phosphorylation that blocks transport from the
ER, blocked virus release by 78% (Fig. 5). In contrast,
incubation of cells with monensin, a drug that inhibits
budding from the Golgi apparatus, only slightly blocked
virus release with 78% of control viral progeny being found
in the supernatant (P  0.05, Fig. 5). The lack of a statis-
tically significant effect by monensin (Fig. 5) supports the
conclusion that rotavirus release into the media bypasses the
Golgi complex, as previously reported (Jourdan et al.,
1997). Early studies demonstrating that virion-associated
VP7 lacks complex carbohydrate modifications were also
interpreted as indicating that rotavirus did not enter a Golgi-
associated pathway during maturation (Kabcenell and At-
kinson, 1985). Although our release experiments were per-
formed after 16 h of infection, the inhibition of viral release
in cholesterol-depleted cells could have been due to drug
effects occurring at earlier steps of the viral replication
cycle, not simply on viral release. To rule out this possibil-
ity, we measured total viral yield (cell associated plus virus
in the supernatant) under the same conditions; the total
production of infectious virus was not affected by treating
the cells with mcdx, mevinolin, or both (not shown).
Taken together, these results demonstrate that disruption of
rafts with cholesterol-depleting drugs specifically inhibits
rotavirus release into the supernatant, as opposed to inhibi-
tion of total viral replication, confirming that rotaviruses use
raft microdomains for transport to the cell surface.
Rotavirus associates with lipid rafts in intestinal epithelial
cells in vivo
In efforts to see whether rotavirus associates with rafts
during a natural infection in vivo as well as in cell culture,
7- to 10-days-old mouse pups were infected with wild-type
murine rotavirus EC (ECw). After 18 h of infection the mice
were sacrificed; small intestines were isolated and the TX-
100 insoluble components of enterocytes membranes from
mock- or rotavirus-infected mice were analyzed by Opti-
Prep gradients, SDS–PAGE, and Western blot as described.
We used a polyclonal antibody against RRV to detect rota-
virus proteins, and as can be seen in Fig. 6 (EC lane), this
antibody reacted weakly with EC VP2 and more strongly
with EC VP6 and VP7. We found that at steady state in
enterocytes isolated from rotavirus infected pups. TX-100
failed to solubilize a proportion of the newly synthesized
virus as evidenced for the presence of the viral structural
proteins VP2, VP6, and VP7 in the detergent-insoluble
fractions (fractions 3 and 4). The polyclonal antibody also
Fig. 6. Rotavirus associates with rafts during replication in mouse intes-
tines. BALB/c pups were orally infected with ECw rotavirus and entero-
cytes from control and rotavirus-infected mice were purified after 18 h of
infection as described under Materials and methods. The isolated entero-
cytes were lysed with cold TX-100 lysis buffer and rafts were purified as
described. Each fraction was diluted, pelleted by ultracentrifugation, and
analyzed by SDS–PAGE and Western blot. (A) Detection of rotavirus
proteins with a polyclonal serum against RRV. (B) Detection of GM1 with
biotinylated ChTX. A representative Western blot of at least three exper-
iments is shown. Molecular weight markers are indicated.
Fig. 5. Cholesterol depletion affects rotavirus release. At 16 h postinfection
the cell-culture supernatant of RRV-infected Caco-2 cells was collected,
frozen, and thawed and the titer of the released virus was determined by
FFU. Mevinolin (10 M) was added to cells 24–28 h before infection and
was mantained during the infection time. 10 mM mcdx was added to the
infected cells 1 h prior harvesting and 50 M monensin or 50 M CCCP
was added to the corresponding wells after 12 h of infection. Results are
expressed as percentage of infectious virus recovered in the cell-culture
supernatant. 100% (9.5  106) represents the infectivity in the supernatant
of nontreated cells. Values are means  standard error from at least three
experiments. A representative of at least three experiments is shown. *P 
0.05, one-sample t-test.
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reacted with a band of about 70 kDa distributed throughout
the gradient; we attribute this reactivity to nonspecific bind-
ing since this band was also detectable in Western blots of
gradients from noninfected mice (not shown). Rotavirus
proteins were also detected in the cytosolic fractions of the
gradient, although in a different proportion from the cell-
culture experiments (compare bottom fractions from Figs. 1
and 6). This difference is due to differences in the experi-
mental procedure in the two experiments. The gradient
fractions of the in vivo experiments were pelleted before
electrophoresis to increase the yield of viral proteins from
the intestines. Hence, we enriched for viral proteins assem-
bled into virus particles. The shedding of rotavirus antigen
following oral administration of the raft fractions to mice
showed that ECw isolated from these fractions is able to
infect and replicate in intestines of adult mice (not shown).
To confirm that fractions 3 and 4 from the enterocyte prep-
aration corresponded to the raft-containing fractions, we
looked for the presence of GM1 as a lipid raft marker. We
use the B subunit of ChTx, which specifically binds this
ganglioside. As expected, GM1 was abundant in fractions 3
and 4 (Fig. 6B), indicating that these fractions are enriched
for rafts. Taken together, these results demonstrate that
rotavirus associates with rafts in epithelial cells during a
natural infection in vivo as well as in Caco-2 cells in vitro.
Discussion
We characterized the association of RRV with lipid rafts
during the replication process. We found that newly syn-
thesized rotavirus particles associate with rafts in tissue
culture cells and during a natural infection. The demonstra-
tion that rotavirus is associated with raft membranes in the
intestine implies that this association probably plays an
important role in viral pathogenesis as well as being an
interesting cell biologic observation. To determine if the
increase of viral proteins in the raft fractions reflected an
association of infectious rotavirus particles with rafts, we
measured infectivity and genomic dsRNA in the raft-en-
riched gradient fractions. An increase of rotavirus infectiv-
ity as well as the enrichment of dsRNA was indeed found in
these raft fractions. Further analysis using double-immun-
ofluorescence staining, confocal microscopy, and specific
markers for lipid rafts and virion-assembled protein dem-
onstrated colocalization of these markers within the cell. We
also found that treatment of cells with drugs that interfere
with rafts formation altered the migration of RRV particles
in density gradients and reduced the secretion of infectious
particles into the cell-culture medium. These findings
strongly support the conclusion that infectious rotavirus is
transported to the cell surface using a raft-dependent path-
way.
The association of the nonstructural protein NSP4 with
rafts after 6 h of infection is noteworthy and was confirmed
by immunoprecipitation using a monoclonal antibody that
specifically recognizes NSP4 (data not shown). This finding
was surprising because it has been previously reported that
this protein migrates in the raft fraction only at later times of
infection (Sapin et al., 2002). This discrepancy probably can
be explained by differences in the protein detection system
used. Sapin and co-workers (Sapin et al., 2002) detected
rotavirus proteins by Western blot and we used radioactive
labeling, which is likely to be more sensitive. The associa-
tion of NSP4 with rafts is potentially significant for two
reasons: On the one hand, this protein plays an important
role during the final steps of virus morphogenesis, while on
the other hand it is a key factor in rotavirus pathogenesis.
NSP4 has been classified as a viral enterotoxin because it
induces diarrhea when injected in infant mice (Ball et al.,
1996). Physiological evidence suggests that NSP4 activates
a signal transduction pathway that increases [Ca2]i by
mobilizing Ca2 from the ER, resulting in transepithelial
chloride secretion and diarrhea (Ball et al., 1996). A pro-
posed mechanism of action of this enterotoxin is that NSP4
expressed in infected cells is released into the external
medium and subsequently interacts with a specific receptor
on adjacent cells (Ball et al., 1996; Zhang et al., 2000). The
recent data of a direct interaction between NSP4 and caveo-
lin-1, as well as the preferential interaction of NSP4 and the
NSP4114–135 peptide with membrane vesicles that mimic the
properties of caveolae, suggest that the transport of NSP4 to
the plasma membrane is dependent on interactions with
caveolin-1 (Ball et al., 2002; Huang et al., 2001). The
findings presented here provide further evidence to support
the idea that NSP4 is released from the infected cell and
suggest that NSP4 and/or its functional enterotoxic peptide
rely on the intracellular trafficking pathway of lipid rafts to
be secreted from the infected cells.
The role of lipid rafts in assembly and/or budding of
enveloped viruses is well documented. The hemagglutinin
(HA) and neuraminidase of influenza virus are recovered in
lipid rafts during their transport to the cell surface (Kundu et
al., 1996; Skibbens et al., 1989). Recently, based on the
detergent insolubility of the lipid and protein constituents of
influenza fowl plague virus (FPV), it has been proposed that
FPV selectively incorporates lipid rafts into its envelope
during its assembly process (Scheiffele et al., 1999). More-
over, Pickl and colleagues (2001) showed that viruses from
different viral families incorporate molecular constituents of
rafts in their envelopes. During HIV-1 replication the asso-
ciation of Env and Gag proteins with lipid rafts or raft-like
membrane domains has been shown to be critical for virion
packing and release (Campbell et al., 2001; Lindwasser and
Resh, 2001). The recent finding that rotavirus structural
protein VP4 associates with rafts as well as the presence of
infectious rotavirus particles in these detergent-resistant
membranes (Sapin et al., 2002) prompted us to characterize
the association of rotavirus with rafts to determine if this
virus uses these membrane structures for transport to the
cell surface.
It has been proposed that apical secretion might be an
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important mechanism in the pathogenesis of several nonen-
veloped viruses that infect epithelial surfaces because this
apical release could limit or direct the dissemination of the
infection to specific host- target cells (Clayson et al., 1989;
Tucker et al., 1993). The vectorial targeting of rotavirus
progeny to the apical surface of epithelial monolayers was
first demonstrated using Caco-2 cells (Jourdan et al., 1997).
Jourdan et al. detected RRV-infectious particles almost ex-
clusively in the apical compartment of filter-grown cells and
virion-containing vesicles were observed by electron mi-
croscopy in the cytoplasmic area lining the apical surface of
the brush border membrane. The exit of viral progeny from
the infected cell seems not to proceed by secretion via the
Golgi apparatus, but to occur from the ER to the apical
plasma membrane by a nonconventional vesicular transport
mechanism (Jourdan et al., 1997). We believe that this
vesicular transport uses a raft-dependent pathway and we
have provided several lines of evidence to support this
conclusion. First, we and others have found that infectious
rotavirus particles migrate in the raft-containing fraction
(Sapin et al., 2002 and Figs. 1 and 2) and this association
was not due to an incomplete detergent extraction process
(Fig. 1C) nor to an intrinsic low buoyant density of the
infectious particle (data not shown). We also demonstrated
that the infectivity associated with raft fractions was due to
the presence of triple-layered particles and not to a nonspe-
cific enhancement of infectivity of double-layer particles by
lipids present in the fractions. To demonstrate that the as-
sociation of rotavirus with rafts that was seen following
detergent extraction of cells was representative of intracel-
lular events, we performed colocalization experiments be-
tween the lipid raft marker GM1 and de novo assembled
triple-layered particles (Fig. 3). In addition to the colocal-
ization between GM1 and mAb 159, which specifically
stains VP7 assembled into virus particles, we detected little
overlapping staining between GM1 and mAb 60 or GM1 and
VP6 (mAb 255/60). This result was anticipated since these
later two antibodies efficiently stain nonassembled rotaviral
proteins, which are the more abundant antigens in the in-
fected cell.
We reasoned that since cholesterol is a critical factor for
the formation of lipid rafts, the removal of cholesterol from
the infected cell should affect the partitioning of rotavirus
proteins into lipid rafts. As predicted, treatment of the cells
with mevinolin reduced the percentage of viral proteins in
the raft fraction, and cholesterol extraction with mcdx had
a more dramatic effect on the association of RRV particles
with rafts. Moreover, the maximum effect on rotavirus as-
sociation with rafts was observed when the infected cells
were subjected to simultaneous treatment with both drugs
(Fig. 4E). Treatment of cells with these two agents has also
been shown to affect the association of the influenza HA
with lipid rafts and to decrease the arrival of the HA protein
to the apical cell membrane (Keller and Simons, 1998).
Cholesterol depletion also reduced the release of rotavirus
infectious particles into the media at the cell surface. Re-
cently, an inhibition of viral particle formation was also
observed in cholesterol-depleted cells infected with Molo-
ney murine leukemia virus (Pickl et al., 2001).
The association of rotavirus particles with lipid rafts and
the link to viral release into the media during infection
raises two important questions. What is the mechanism of
association and, where does this association take place? It is
known that proteins are structural components of lipid raft;
proteins with GPI-anchored moieties (Brown and Rose,
1992; Sargiacomo et al., 1993), transmembrane proteins
(Sargiacomo et al., 1993; Skibbens et al., 1989), and double-
acylated tyrosine kinases of the src family (Casey, 1995;
Resh, 1994) are present in rafts. It has been shown that
determinants that link proteins to rafts also act as sorting
determinants for apical transport, in the case of transmem-
brane proteins, glycosylation, and specific amino acids res-
idues in the transmembrane domain appear to cooperate to
target these proteins to the apical surface and to ensure
association with rafts (Kundu et al., 1996; Scheiffele et al.,
1997).
The most plausible candidate to be responsible for the
association of rotavirus with lipid rafts is the outer capsid
protein VP4 since this protein was found associated with
rafts at early times after infection (Sapin et al., 2002). More
precisely, these authors suggested that the galectin-like do-
main of VP8 could be responsible for this interaction. How-
ever, the question of how the immature viral particle trans-
locates to rafts remains open. We believe that VP7 and the
nonstructural protein NSP4 are also possible candidates for
raft targeting. VP7 fulfills the following two requisites
found in other transmembrane raft-associated proteins: (i) it
is N-glycosylated and (ii) is an integral membrane protein of
the ER, and it has been implicated in membrane interactions
(Falconer et al., 1995; Ruiz et al., 1997). Since VP7 is a
N-glycosylated protein and is located in the ER membrane
(Kabcenell and Atkinson, 1985), we speculate that VP7
could behave as a transmembrane protein and act as a
sorting determinant to anchor the ER-intermediate particles
to rafts, engaging them in the apical transport route. Pre-
sumably, NSP4 could also play a role in the targeting of
virion to rafts as they are formed during ER budding. In-
creasing evidence supports the idea that NSP4 plays an
important role during virus maturation and release. First this
protein functions as a viral receptor for the double-layered
particle in the ER lumen and second, NSP4 blocks the traffic
of vesicles to the plasma membrane in a pre- Golgi step (Xu
et al., 2000). One attractive explanation for the finding of
NSP4 in rafts but not associated with TLP’s is that this
protein also function as a “raft receptor” that transiently
binds double-layered particles for their translocation into
these lipid microdomains where VP4 and perhaps VP7 are
going to be assembled. The extensive colocalization and
heterooligomeric structures between VP4, VP7, and NSP4
(Gonzalez et al., 2000; Maass and Atkinson, 1990) support
the idea that these three proteins interact extensively where
active virion assembly is taking place. Alternatively, it is
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possible that NSP4 and rotavirus TPLs are associated with
different populations of rafts. The existence of subtypes of
detergent-resistant domains has been reported previously
(Lindwasser and Resh, 2001; Simons and Ikonen, 1997).
Interesting, the blockage of the transport of vesicles from
the ER–Golgi intermediate compartment (ERGIC) to the
Golgi complex by NSP4 was recently reported (Xu et al.,
2000). Since NSP4 interferes with the secretory pathway in
a pre-Golgi step and the virus appears to be released by an
atypical vesicular system that bypasses the Golgi, it is
tempting to speculate that rotavirus directs the cellular se-
cretory machinery to favor its own release.
It is generally held that raft assembly takes place in the
Golgi apparatus. The synthesis of glycerolipids starts in the
ER and the headgroups of the sphingolipids are added in the
Golgi complex (Simons and Ikonen, 1997). The outline of
raft biosynthesis states that nascent cholesterol partitions
preferentially into nonrafts membranes but following arrival
at the Golgi it partitions with glycosphingolipids into rafts
and subsequently is transported to the cell surface (Simons
and Ikonen, 2000). If raft assembly takes place in the Golgi
and rotavirus progeny reaches the apical cell surface by a
nonconventional vesicular pathway that bypasses the Golgi
complex, where do the virus and raft vesicles associate? We
suggest that the association could take place in an interme-
diate compartment between the ER and the Golgi. The
participation of ERGIC in anterograde and retrograde
movement of vesicles between the ER and the Golgi is
documented (Hauri et al., 2000). Moreover, it has been
proposed that this tubular organelle is responsible for the
return of cholesterol from the Golgi to the ER (Simons and
Ikonen, 2000). Recently, Mirazimi et al. proposed that the
maturation of VP7 occurs in a different compartment than
the ER, possibly the ERGIC (Mirazimi et al., 1996). Based
on these observations, we propose that it is possible that raft
vesicles recruited by the retrograde movement from Golgi
to ER fuse with ERGIC- rotavirus-containing vesicles and
subsequently are transported to the cell surface as newly
synthesized rafts. A second possibility is that rotavirus par-
ticles associate with a subpopulation of lipid rafts that by-
passes the Golgi complex. The isolation of Triton- insoluble
membranes from subcellular preparations enriched in ER
membranes from mammalian cells (Sevlever et al., 1999),
the presence of rafts in the ER of yeast (Bagnat et al., 2000),
and the finding that a pool of newly synthesized cholesterol
in mammalian cells uses a transport route to the plasma
membrane that bypasses the Golgi complex (Heino et al.,
2000) are several lines of evidence that suggest that the
assembly of lipid rafts start in the ER and can bypass the
Golgi.
Our current studies do not identify at which of the po-
tential sites the raft–rotavirus interaction actually takes
place. Further studies directed to elucidate the cellular com-
partment where rotavirus associates with rafts need to be
performed. The association of newly synthesized rotavirus
particles in vivo with lipid rafts described in this work, in
conjunction with the unique maturation and transport pro-
cesses of rotaviruses to the cell surface, make this virus a
good model system to study alternative pathways of intra-
cellular vesicular transport.
Materials and methods
Materials
Media, Hank’s balanced salt solution (HBSS), and re-
agents for cell culture were acquired from BioWhittaker
(Walkersville, MD). Promix L[35S], ECL reagent, and flu-
orescein isothiocyanate conjugated streptavidin (FITC-
streptavidin) were acquired from Amersham Pharmacia
(Piscataway, NJ). Cyclohexamide was acquired from Cal-
biochem (San Diego, CA). OptiPrep was acquired from
Nycomed (Oslo, Norway). Anti-human placental alkaline
phosphatase was acquired from Dako (Carpinteria, CA).
Goat anti-mouse IgG coupled to alkaline phosphatase, goat
anti-rabbit IgG coupled to peroxidase, peroxidase-labeled
streptavidin, and BCIP-NBT were acquired from Kirkeg-
aard & Perry (Gaithersburg, MD). Texas red conjugated
goat anti-mouse IgG (mouse Txred) was acquired from
Southern Biotechnology Associates (Birmingham, AL).
Vectashield was acquired from Vector Laboratories (Bur-
lingame, CA). Methyl--cyclodextrin, mevinolin, and all
other reagents were from Sigma (St. Louis, MO). Monoclo-
nal antibodies 159, 255/60, and 60 have been previously
described (Dormitzer et al., 1992).
Cells and virus replication
The human intestinal epithelial cell line Caco-2 and
MA104 cells, obtained from American Type Culture Col-
lection, were grown in RPMI-1640 and Medium 199, re-
spectively, as described elsewhere (Cuadras et al., 2002).
RRV was propagated in MA104 cells as described previ-
ously (Cuadras et al., 2002). Wild-type murine rotavirus EC
was prepared from intestinal homogenates as previously
described (Franco et al., 1997). Infectious viral titer was
determined by oral inoculation of 5- to 8- day-old BALB/c
mice with serial 10-fold dilutions of the intestinal homog-
enates and monitored daily for diarrhea onset. Virus diar-
rhea dose 50 (DD50) was calculated using the Reed and
Muench method (Franco et al., 1997).
Pulse-chase experiment
At 10–15 days postseeding Caco-2 cells were washed
twice with RPMI medium and infected with a multiplicity
of infection (m.o.i.) of 10 focus- forming units (FFU)/cell of
trypsin-activated RRV. All the incubations during infec-
tions were performed at 37°C unless indicated. After 90 min
the inoculum was removed, and the monolayers were
washed and incubated for 3.5–4 h. The cells were then
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starved in methionine–cysteine-free medium for 1 h and
labeled for 15 min with 150 Ci/ml of Promix L[35S]. The
pulse was ended by incubation with chase medium (RPMI
medium supplemented with 1 mM cycloheximide and 10
mM L-methionine) for different periods of time (0, 20, or 60
min). At the end of the chasing time the cells were washed
with cold phosphate-buffered saline (PBS), pelleted (500 g),
and washed again with cold PBS.
Some experiments were performed on cells that were
incubated with 10 M mevinolin [dissolved in ethanol and
activated as described (Fenton et al., 1992)] for 36 h prior to
infection (24 h in complete RPMI and 12 h in serum-free
RPMI). For cholesterol depletion, 10 mM mcdx was added
to the cells during starvation. For combined treatment with
these drugs, the cells were treated with mevinolin, infected
with RRV, and then incubated with mcdx at the beginning
of the methionine–cysteine starvation. For each drug treat-
ment the cells were labeled as described above and chased
for 60 min in chase medium. Each drug concentration was
maintained in the starvation, labeling, and chase media. The
cells were washed and recovered as described above.
Triton X-100 extraction and membrane fractionation
The cellular pellets were homogenized by pipetting in
400 l of cold 1% Triton X-100 lysis buffer (25 mM Tris–
HCl pH 7.5, 150 mM NaCl, 1 mM CaCl2, 1% Triton X-100,
1 mM PMSF, and 1 g/ml of leupeptin and pepstatin A).
After 30 min on ice, each sample was adjusted to 40%
OptiPrep placed in the bottom of a centrifuge tube and
overlayed with discontinuous layers of 1.2 ml of 30 and
25% and 0.8 ml of 5% OptiPrep in 0.1% TX-100 lysis
buffer. The gradients were ultracentrifuged at 340,000 g at
4°C for 4 h. The gradients were fractionated and stored at
20°C. For some experiments, the viral particles contained
in each fraction were pelleted for 2 h at 178,000 g and
resuspended in TNC (25 mM Tris–HCl pH 7.5, 150 mM
NaCl, 1 mM CaCl2).
Migration of purified triple-layered particles in OptiPrep
gradient
MA104 cells grown in 75-cm2 flasks were infected with
10 FFU/cell of trypsin-activated RRV; viral proteins were
radiolabeled with 20 Ci/ml of Promix L[35S] from 5 hpi
until viral lysate was harvested (18–24 hpi). The viral
particles were purified by ultracentrifugation in CsCl gra-
dients as described elsewhere (Falconer et al., 1995). The
band corresponding to triple-layered particles was recov-
ered by puncture, dissolved in TNC, and pelleted 2 h at
90,000 g. The pellet was resuspended in 100 l of TNC and
the protein composition was analyzed by SDS–PAGE and
fluorography. For the in vitro reconstitution and mixing
experiments, 20 l of the 35S-labeled TLPs was mixed and
incubated for 30 min on ice with a cellular pellet of Caco-2
cells (25-cm2 flask) extracted with cold TX-100 lysis buffer
as described above. The mix was adjusted to 40% OptiPrep
and a discontinuous 5–30% OptiPrep gradient was layered
over it. The gradient was fractionated and analyzed by
SDS–PAGE and fluorography.
Gel electrophoresis and Western blot
To analyze the 35S-labeled proteins, aliquots of each
fraction were mixed with Laemmli sample buffer, boiled,
and separated by electrophoresis on SDS–PAGE. After
electrophoresis, the gels were treated for fluorography and
exposed at 70°C. For Western blots, electrophoresis was
performed as described and the proteins were transferred to
PVDF membrane, probed with a 1:1000 dilution of mono-
clonal mouse anti-human PLAP, and detected with goat
anti-mouse IgG coupled to alkaline phosphatase; the signal
was developed using BCIP-NBT.
Genomic dsRNA was isolated from 100 l of each
fraction after incubation in denaturation buffer (10 mM
EDTA, 10 mM Tris–HCl pH 6.8, 10 mM NaCl, 1% SDS)
and phenol–chloroform extraction. RNA was ethanol pre-
cipitated, resuspended in H2O, and subjected to electro-
phoresis. RNA bands were detected by staining with silver
nitrate (Broome et al., 1993).
Quantification of viral release
Measurement of viral release was performed basically as
described (Jourdan et al., 1997). Briefly, Caco-2 cells in
24-well tissue culture plates were infected with 10 FFU/cell
of trypsin-activated RRV. One hour postinfection, the inoc-
ulum was removed and fresh serum-free RPMI was added
for an additional period of 15 h. Cell-culture supernatant
was collected, frozen, and thawed twice and the viral titer
was determined by FFU assay on MA104 cells. Mevinolin
(10 M) was added to cells 24–28 h before infection and
maintained during the infection time; 10 mM mcdx was
added to the infected cells 1 h prior to harvesting and
monensin and CCCP (50 M each) were added to the
corresponding wells after 12 h of infection.
For measurement of total virus yield the cells were in-
fected in the presence or absence of drugs as described
above. The cell-associated virus plus the virus in the super-
natant were collected by freezing/thawing twice. The cell
debris was pelleted and the infectious virus in the superna-
tant was titered by the FFU assay.
Virus titration
An aliquot of each fraction of each condition of the viral
release experiment was diluted 1:10 in medium 199 and
activated with 10 g/ml of trypsin for 30 min at 37°C.
Confluent monolayers of MA104 cells in 96-well plates
were infected with serial twofold dilutions for 1 h at 37°C.
The inoculum was removed; the cells were washed and
incubated for 12–15 h at 37°C. The cells were fixed and
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permeabilized with 70% methanol for 30 min at room tem-
perature. The infected cells were detected by an immuno-
peroxidase focus detection assay (Lizano et al., 1991).
Rafts isolation from intestinal epithelium
Seven- to ten-day-old BALB/c mice were orally infected
by gavage with 106 DD50 of ECw rotavirus. Enterocytes
from control and rotavirus-infected mice were purified after
18 h of infection by standard protocols previously described
(Stahl et al., 1999). Briefly, small intestines were removed
and thoroughly rinsed with cold PBS containing 40 g/ml
PMSF. The intestines were longitudinally opened, cut into
1- to 2-cm fragments and incubated for 10 min in 30 ml of
Ca2–Mg2-free HBSS supplemented with 0.1 M sucrose,
20 mM EDTA, and 40 g/ml of PMSF with gentle stirring
at room temperature. The isolated enterocytes were allowed
to settle on ice and were washed two times with cold PBS
by centrifugation. The cellular pellet was homogenized with
TX-100 lysis buffer for 30 min on ice, and the low-density
membrane component was isolated after centrifugation on
OptiPrep gradients as described above. Each fraction was
diluted in 5 ml of 0.1% TX-100 lysis buffer, pelleted by
ultracentrifugation (2 h, 178,000 g), and stored at 20°C.
Viral proteins were analyzed by gel electrophoresis and
Western blot as described above using a rabbit polyclonal
antiserum against RRV as a primary antibody and goat
anti-rabbit IgG coupled to peroxidase as a secondary anti-
body. For GM1 detection the blotted membranes were incu-
bated with 0.2 g/ml of biotin-labeled B subunit of ChTx
and 0.1 g/ml of peroxidase-labeled streptavidin. The sig-
nal was developed using ECL reagent.
Confocal microscopy
Caco-2 cells were seeded onto tissue culture chamber
slides and 10 days postseeding the cells were infected or
mock infected at an m.o.i. of 1 FFU/cell of trypsin-activated
RRV in RPMI without FBS. 16hpi the cells were washed
and fixed for 4 min with 3.7% formaldehyde in PBS at
10°C. The fixed cells were permeabilized for 5 min with
methanol at 20°C and blocked 1 h at 37°C in PBS 2%
bovine serum albumin (BSA). For staining with mAb 159
the cells were fixed for 20 min with 4% paraformalde-
hyde–5% sucrose in PBS and permeabilized with 0.2%
TX-100 for 10 min at room temperature. The cells were then
costained for 1 h at 37°C with 25 g/ml of ChTX and the
indicated dilution of each antirotavirus antibody in PBS–
0.2% BSA. The dilutions of ascites fluid of rotavirus-spe-
cific mAbs used for the staining were as follows: mAb
255/60 (VP6) 1:50, mAb 60 (VP7) 1:10, and mAb 159
(VP7) 1:50. After washing with PBS, the cells were coin-
cubated with streptavidin-FITC and mouse Txred (1
g/ml each) for 30 min at 37°C. The cells were washed and
the slides were mounted with Vectashield (Vector Labora-
tories). The slides were analyzed using an Eclipse TE300
confocal microscope (Nikon, USA) and LaserSharp MRC-
1024 software (Bio-Rad). Double staining was analyzed
using the 488- to 568-nm band of an argon-krypton laser.
The digital images were processed using Adobe Photoshop
software.
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